Bisphosphonates, raloxifene and teriparatide for treating osteoporosis

24th August 2018 by Louise Hudman

Bisphosphonates, raloxifene and teriparatide for treating osteoporosis

This summary is based on 3 recent NICE guidelines:

Previous guidance was rather complicated in that different bisphosphonates could be used at different levels of risk. This has all been simplified as the cost of the drugs has reduced. Advice on using raloxifene and teriparatide hasn’t changed. Strontium and etidronate are no longer marketed in the UK.

There is quite a nice decision aid that can be used with patients on what the risk reduction is with different treatments.

Who is eligible for bisphosphonate treatment?

Read for free

Sign up to access everything.

Free trial

Login

Already a member? Login to view this content.

Login

"Work as GP locum provides me both flexibility and autonomy together with great job satisfaction. However, there are some complexities one needs to address in starting out and doing everything right.

I've generally found answers to any issues I've had on the NASGP website – an excellent repository of very relevant information. The blog and magazines alone are almost worth the small costs of membership. The fact that NASGP is run by motivated fellow GPs gives me confidence in their guidance and advice.

LocumDeck makes my running things as a self-employed GP almost effortless - I don't think I would want to work without it. Invoicing is streamlined and the website is very user-friendly. After a busy week at work, the last thing you want is to spend hours on business admin. LocumDeck is a real timesaver.
"

Dr James O’Mahony

See the full list of features within our NASGP membership plans

Membership